Ketamine by NRX Pharmaceuticals for Bipolar Disorder (Manic Depression): Likelihood of Approval

Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression).

Feb 20, 2024 - 18:00

Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression).

Read the original article

Tags:

Previous Article

NA-921 by Biomed Industries for Fragile X Syndrome: Likelihood of Approval

SAR-442970 by Sanofi for Hidradenitis Suppurativa: Likelihood of Approval

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Opinion: I went on a mind-boggling journey to get my son’s ADHD medication covered by insurance — twice

Opinion: I went on a mind-boggling journey to get my so...

Jan 6, 2024

Melpida by Elpida Therapeutics for Paraplegia: Likeliho...

Nov 4, 2023

Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech

Vivek Ramaswamy’s brashness made waves in the Republica...

Aug 25, 2023